Bosniak IIF cyst is an intermediary cystic renal lesion that is more complex than simple cysts but has low enough malignancy risk (5-15%) to not require surgery. According to the 2019 updated Bosniak classification, it may show 4 or more thin septa (≤3 mm), thin septa or wall (≤3 mm) with minimally perceived enhancement, ≥3 cm hyperdense cyst, or nodular/thick calcification. The 'F' stands for 'follow-up' — since definitive benign vs malignant differentiation cannot be made, 5-year imaging follow-up is required. Lesions remaining stable during follow-up are considered benign; those showing progression (increased enhancement, solid component development, size increase) are upgraded to Bosniak III and surgery is considered. Constitutes 5-10% of renal cystic lesions. Progression rate during follow-up is approximately 10-12% — most lesions are stable. MRI evaluates septal enhancement more sensitively than CT and improves classification between Bosniak IIF and III.
Age Range
35-80
Peak Age
55
Gender
Equal
Prevalence
Uncommon
Bosniak IIF cysts share the tubular epithelial origin mechanism of Bosniak II cysts but show additional structural complexity. Increased septa count (4+) reflects incorporation of more adjacent tubular structures or more fibrous band formation within the cavity. Minimally perceived enhancement is a critical concept: no measurable enhancement (<15-20 HU increase on CT) exists but slight post-contrast signal increase is perceived on visual assessment — this perceived enhancement may reflect minimal capillary activity without full vascularization or may result from CT/MR artifacts (pseudoenhancement). This uncertainty forms the basis of the IIF category. Thick or nodular calcifications represent more advanced dystrophic calcification from prior hemorrhage or inflammation — calcification amount and pattern do not correlate with malignancy but thick calcifications may mask potential solid components behind them. Inclusion of ≥3 cm hyperdense cysts reflects higher risk of intracystic hemorrhage or protein accumulation with increasing size and slightly increased malignancy risk compared to small hyperdense cysts. On imaging, septa appear as thin linear structures at soft tissue density on CT, and as T2 hypointense, mildly enhancing thin lines on MRI — MRI's superior contrast resolution provides advantage over CT for evaluating septal enhancement.
Non-measurable but visually perceptible minimal enhancement increase in septa or wall — the most critical and most subjective diagnostic criterion of Bosniak IIF. May reflect true minimal vascularization or pseudoenhancement — inability to make definitive distinction is the basis for the IIF category and follow-up requirement. MRI subtraction is superior to CT for this assessment.
CT shows 4 or more thin septa (≤3 mm thickness) within the cyst cavity. Septa are smooth-contoured and thin but may show minimally perceived enhancement on contrast-enhanced series — this enhancement is not measurable (<15-20 HU increase) but is perceptible on visual assessment. Careful comparison of non-contrast and contrast-enhanced series is required. Having 4+ septa is the criterion for upgrading from Bosniak II to IIF. Homogeneous thickness and smooth contour of septa are benign features — irregular thickness or nodularity suggests upgrading to Bosniak III.
Report Sentence
Multiple (4+) thin septa (≤3 mm) in the renal cystic lesion with minimally perceived enhancement on contrast-enhanced series; consistent with Bosniak category IIF, imaging follow-up recommended.
Thick, nodular calcification in cyst wall or septa — more prominent and irregular pattern than thin calcification (Bosniak II). Calcification thickness may be >2 mm with focal nodular accumulations. In the 2019 Bosniak classification, calcification alone does not upgrade category — evaluated together with enhancement presence/absence. However, thick calcifications may mask potential enhancing tissue behind them — careful MRI evaluation is recommended.
Report Sentence
Thick, nodular calcification in the cystic lesion; MRI recommended for evaluating potential enhancing component behind calcification.
MR contrast-enhanced T1 fat-suppressed sequences evaluate septal and wall enhancement more sensitively and specifically than CT. Subtraction images of pre- and post-contrast T1 fat-suppressed series best demonstrate enhancement. In IIF cysts, septa are thin (≤3 mm), smooth, and show minimal enhancement. MRI advantages: (1) gadolinium contrast provides more sensitive septal enhancement detection than CT iodinated contrast, (2) subtraction technique reduces subjective assessment, (3) less partial volume effect than CT. No diffusion restriction expected on DWI as IIF cysts lack solid malignant components.
Report Sentence
Septa in the cystic lesion are thin (≤3 mm) and smooth on MR contrast-enhanced series with minimal enhancement; consistent with Bosniak IIF.
Hyperdense cyst ≥3 cm (≥70 HU on non-contrast CT) is classified as Bosniak IIF — small (<3 cm) hyperdense cysts are Bosniak II. Hyperdense content reflects prior hemorrhage or high protein concentration. No enhancement increase should be present on contrast-enhanced series (HU is already high on non-contrast and remains high on contrast — but no increase). With increasing size, intracystic complexity and malignancy risk slightly increase, hence the ≥3 cm threshold for the follow-up category. On US, hyperdense cysts may appear hyperechoic or anechoic — CT correlation required.
Report Sentence
Hyperdense cystic lesion ≥3 cm ([x] HU on non-contrast CT) in the kidney without measurable enhancement increase on contrast-enhanced series; consistent with Bosniak IIF, follow-up recommended.
On T2-weighted sequences, cyst content is hyperintense (fluid signal), septa appear as hypointense thin lines. Smooth, thin (≤3 mm), homogeneous septa support IIF. Septal count and thickness are best evaluated on T2 — high fluid contrast clarifies septa-cyst interface. Septal irregularity, nodularity, or >3 mm thickness suggests upgrading to Bosniak III. Calcifications appear as signal void on T2.
Report Sentence
Multiple thin, smooth septa in the cystic lesion on T2-weighted MRI; morphology supporting Bosniak IIF classification.
Stability on follow-up imaging (no size change, no new septa or enhancement increase, no solid component development) supports benign behavior. Lesions stable for 5 years are considered benign and may be discharged from follow-up. Progression findings (septal thickening >3 mm, new measurable enhancement, solid nodule development, size increase) require upgrading to Bosniak III and surgical evaluation. Follow-up with CT or MRI: 6-monthly for first 2 years, then annual.
Report Sentence
Bosniak IIF cystic lesion is stable in size and morphology on follow-up imaging; favoring benign behavior, continued follow-up recommended.
Criteria
4+ thin septa (≤3 mm), smooth contour, minimally perceived enhancement. Septa count exceeds Bosniak II (1-3). Cyst content is simple fluid density.
Distinct Features
Most common IIF subtype. Progression rate ~8-10%. Low malignancy risk as long as septa remain smooth and thin. Septal irregularity or thickening is sign of progression.
Criteria
Thick (>2 mm), nodular calcification in septa or wall. No measurably enhancing solid component. Calcification pattern and tissue behind it must be carefully evaluated.
Distinct Features
Calcification may mask enhancement via beam hardening artifact — complementary MRI evaluation recommended. Progression rate is not different from other IIF subtypes.
Criteria
≥3 cm diameter, ≥70 HU on non-contrast CT, no enhancement increase. Upgraded from Bosniak II to IIF due to size.
Distinct Features
T1 hyperintense on MRI (protein/hemorrhage). Subtraction technique must separate T1 hyperintensity from enhancement. Size follow-up important — growth favors progression.
Distinguishing Feature
Bosniak II: 1-3 thin septa (≤2 mm), thin calcification, <3 cm hyperdense — absolutely no enhancement. IIF: 4+ septa, perceived enhancement, thick calcification, ≥3 cm hyperdense. Distinction may be subjective — MRI improves classification.
Distinguishing Feature
Bosniak III: thick irregular septa or wall (≥4 mm), measurable enhancement (>15-20 HU). In IIF, enhancement is perceived but not measurable. This distinction is critical — III requires surgery, IIF requires follow-up.
Distinguishing Feature
Cystic RCC is usually classified as Bosniak III or IV — avid solid enhancing component, irregular thick septa, nodular enhancement. IIF lacks solid enhancing component.
Distinguishing Feature
Multilocular cystic nephroma: cystic mass divided by numerous septa with septal enhancement, no solid nodule — classified as Bosniak III. In IIF, septa are fewer and thinner with minimal/perceived enhancement.
Urgency
surveillanceManagement
surveillanceBiopsy
Not NeededFollow-up
6-monthBosniak IIF is an intermediary category requiring follow-up — no surgical indication. 5-year imaging follow-up recommended: 6-monthly for first 2 years, then annual CT or MRI. Progressing lesions (10-12%) are upgraded to Bosniak III and surgery considered (partial nephrectomy preferred). Lesions stable for 5 years are considered benign. MRI is preferred follow-up modality — no radiation, superior enhancement assessment. When CT is used, low-dose protocol should be applied.
Bosniak IIF cysts require follow-up. CT or MRI every 6 months in the first year, then annually for at least 5 years. ~5% malignancy risk. If progression is observed, upgraded to Bosniak III or IV.